OGEN Doses First Patient in Phase IIa ONP-002 Trial for Concussion, Mackay Hospital Activated March 31, 2026, 40-Patient Study, $9B Global Concussion Market, Intranasal Delivery, CEO Janet Huffman, Dr. James Kelly, HREC Approval, Targets Q4 2026 IND Submission
Oragenics Inc. · Now $0.61
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS